Laser Photonics closes $7.9M stock, warrant sale
Laser Photonics completed a $7.9 million public equity and warrant offering, adding capital for R&D, acquisitions and working capital.
Rhea-AI Filing Summary
Laser Photonics Corp (LASE) reported the closing of a previously announced public offering completed on September 14, 2026, issuing 10,500,000 shares of common stock together with Series B-1 and Series B-2 warrants. The combined public offering price was $0.75 per share and accompanying warrants, generating approximately $7.9 million in gross proceeds before fees and expenses.
Each of the Series B-1 and Series B-2 warrants is exercisable immediately at an exercise price of $0.75 per share; the Series B-1 warrants expire five years from issuance and the Series B-2 warrants expire twenty-four months from issuance. Laser Photonics states it intends to use the net proceeds for research and development of its laser-based technologies, acquisitions, and working capital.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Shares of common stock offered: 10,500,000 shares
Series B-1 warrants: 10,500,000 underlying shares
Series B-2 warrants: 10,500,000 underlying shares
+5 more
8 metrics
Shares of common stock offered
10,500,000 shares
Public offering closed on September 14, 2026
Series B-1 warrants
10,500,000 underlying shares
Warrants issued with the offering
Series B-2 warrants
10,500,000 underlying shares
Warrants issued with the offering
Combined public offering price
$0.75 per share and accompanying warrants
Terms of the September 2026 public offering
Warrant exercise price
$0.75 per share
Exercise price for both Series B-1 and B-2 warrants
Gross proceeds
$7.9 million
Gross proceeds to the company before fees and expenses
Series B-1 warrant term
5 years
Expiration after date of issuance
Series B-2 warrant term
24 months
Expiration after date of issuance
Key Terms
public offering, warrants, exercise price, registration statement on Form S-1, +2 more
6 terms
public offering financial
"announced that it closed its previously announced public offering on September 14, 2026"
A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.
warrants financial
"accompanied by Series B-1 warrants to purchase up to 10,500,000 shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
exercise price financial
"each warrant with an exercise price of $0.75 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
registration statement on Form S-1 regulatory
"A registration statement on Form S-1 (File No. 333-298783) relating to the offering"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of applicable securities laws"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
working capital financial
"use the net proceeds from this offering for research and development ... and working capital"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
Offering Details
secondary
Offering
Offering Type
secondary
Use of Proceeds
Research and development for laser-based technologies, acquisitions, and working capital
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Laser Photonics (LASE) announce in its September 15, 2026 8-K?
Laser Photonics announced the closing of a previously announced public offering completed on September 14, 2026, involving 10,500,000 shares of common stock with Series B-1 and B-2 warrants at a combined price of $0.75, raising approximately $7.9 million in gross proceeds.
What were the proceeds to Laser Photonics (LASE) from the offering?
The offering generated gross proceeds of approximately $7.9 million to Laser Photonics, before deducting the placement agent’s fees and other offering expenses payable by the company.
What are the terms of the Series B-1 and B-2 warrants issued by LASE?
Both Series B-1 and B-2 warrants are exercisable upon issuance at an exercise price of $0.75 per share. The Series B-1 warrants expire five years from issuance, while the Series B-2 warrants expire twenty-four months from the date of issuance.
How does Laser Photonics (LASE) plan to use the net proceeds from the offering?
Laser Photonics intends to use the net proceeds for research and development of its laser-based technologies, acquisitions, and working capital, according to the company’s disclosure.
Which registration statement covered the Laser Photonics (LASE) offering?
The offering was made under a registration statement on Form S-1 (File No. 333-298783), which was declared effective by the SEC on September 10, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
